FRONTEO CEO Masahiro Morimoto Invited to Deliver Special Lecture at 'Medical Industry Growth Strategy Seminar Annual Forum 2026'
NQ Score
54/100
N1 Content Completeness
10
AI Summary (NQ-processed)
FRONTEO CEO Masahiro Morimoto will speak at the 'Medical Industry Growth Strategy Seminar Annual Forum 2026' on July 15, 2026. The forum gathers 500 leaders from industry, academia, and government to discuss the future of Japan's medical sector, where Morimoto will present on AI-driven drug discovery.
AI Analysis
Frequently Asked Questions
- Q: What is FRONTEO's 'Drug Discovery AI Factory'?
- A: It is an AI-driven drug discovery support service that utilizes the proprietary natural language processing AI 'KIBIT' to assist researchers in analyzing gene networks and identifying target molecules.